Home LiteratureArticle Details
PMID: 9811731 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Protective role of the virus-specific immune response for development of severe neurologic signs in simian immunodeficiency virus-infected macaques.

Journal of virology ·Vol. 72 ·No. 12 ·1998-12-00 ·Pages 9940-7

Sopper S, Sauer U, Hemm S, Demuth M, Müller J, Stahl-Hennig C, Hunsmann G, ter Meulen V, Dörries R

Abstract

The pathogenesis of human immunodeficiency virus-associated motor and cognitive disorders is poorly understood. In this context both a protective and a harmful role of the immune system has been discussed. This question was addressed in the present study by correlating the occurrence of neurologic disease in simian immunodeficiency virus (SIV)-infected macaques with disease progression and the humoral and cellular intrathecal antiviral immune response. Overt neurologic signs consisting of ataxia and apathy were observed at a much higher frequency in rapid progressor animals (6 of 12) than in slow progressors (1 of 7). Whereas slow progressors mounted a strong antiviral antibody (Ab) response as evidenced by enzyme-linked immunosorbent and immunospot assays, neither virus-specific Ab titers nor Ab-secreting cells could be found in the cerebrospinal fluid (CSF) or brain parenchyma of rapid progressors. Similarly, increased infiltration of CD8(+) T cells and cytotoxic T lymphocytes specific for viral antigens were detected only in the CSF of slow progressors. The finding that neurologic signs develop frequently in SIV-infected macaques in the absence of an antiviral immune response demonstrates that the immune system does not contribute to the development of motor disorders in these animals. Moreover, the lower incidence of neurologic symptoms in slow progressors with a strong intrathecal immune response suggests a protective role of the virus-specific immunity in immunodeficiency virus-induced central nervous system disease.

MeSH Terms
AIDS Dementia Complex/immunology,prevention & control Animals Antibodies, Viral/biosynthesis,cerebrospinal fluid Blood-Brain Barrier/immunology Central Nervous System Infections/immunology,prevention & control Disease Models, Animal Humans Immunity, Cellular Immunoglobulin G/biosynthesis,cerebrospinal fluid Macaca mulatta Simian Acquired Immunodeficiency Syndrome/immunology Simian Immunodeficiency Virus/immunology,pathogenicity Time Factors
Chemicals
Antibodies, Viral Immunoglobulin G
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Sopper S
Institut für Virologie und Immunbiologie, Julius-Maximilians-Universität, Würzburg, Germany. sopper@vim.uni-wuerzburg.de
Sauer U
Hemm S
Demuth M
Müller J
Stahl-Hennig C
Hunsmann G
ter Meulen V
Dörries R
References (48)
48 references, click to expand
  1. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells.
    J Immunol Methods. 1983 Feb 25;57(1-3):301-9 PMID: 6338123
  2. Local production of mumps IgG and IgM antibodies in the cerebrospinal fluid of meningitis patients.
    J Med Virol. 1981;8(4):257-65 PMID: 7334360
  3. Humoral immune responses to T cell tropic retrovirus simian T lymphotropic virus type III in monkeys with experimentally induced acquired immune deficiency-like syndrome.
    J Clin Invest. 1986 Nov;78(5):1229-36 PMID: 3771794
  4. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system.
    Clin Chim Acta. 1987 Mar 30;163(3):319-28 PMID: 3581475
  5. Perinatal infection with human immunodeficiency virus. Specific antibody responses by the neonate.
    N Engl J Med. 1987 Sep 3;317(10):611-4 PMID: 3475573
  6. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex.
    Science. 1988 Feb 5;239(4840):586-92 PMID: 3277272
  7. Simian immunodeficiency virus-induced meningoencephalitis: natural history and retrospective study.
    Ann Neurol. 1988;23 Suppl:S101-7 PMID: 2831796
  8. Cerebrospinal fluid lymphocytes from HIV-infected patients synthesize HIV-specific antibody in vitro.
    J Neuroimmunol. 1988 May;18(2):181-6 PMID: 3162735
  9. Simian immunodeficiency virus/delta-induced immunodeficiency disease in rhesus monkeys: relation of antibody response and antigenemia.
    J Infect Dis. 1988 Dec;158(6):1277-86 PMID: 2848903
  10. AIDS and the nervous system: current status and future perspectives.
    Hum Pathol. 1989 May;20(5):410-8 PMID: 2651280
  11. Detection of antibodies against myelin basic protein and increased levels of HIV-IgG antibodies and HIV antigen after solubilization of immune complexes in sera and CSF of HIV infected patients.
    Viral Immunol. 1989;2(1):1-9 PMID: 2472807
  12. Brain-reactive antibodies and the AIDS dementia complex.
    J Acquir Immune Defic Syndr. 1989;2(5):469-71 PMID: 2795448
  13. Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques.
    J Acquir Immune Defic Syndr. 1990;3(11):1023-40 PMID: 2213505
  14. Rhesus monkey macrophages infected with simian immunodeficiency virus cause rapid lysis of CD4-bearing lymphocytes.
    J Gen Virol. 1991 Feb;72 ( Pt 2):317-24 PMID: 1671581
  15. Cerebrospinal fluid anti-cardiolipin antibodies in patients with HIV-1 infection.
    J Acquir Immune Defic Syndr. 1991;4(4):435-41 PMID: 2007978
  16. HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease.
    FASEB J. 1991 Jul;5(10):2391-7 PMID: 2065887
  17. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system.
    Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7438-42 PMID: 1651506
  18. Cognitive and motor impairments associated with SIV infection in rhesus monkeys.
    Science. 1992 Mar 6;255(5049):1246-9 PMID: 1546323
  19. Epidemiology of human immunodeficiency virus encephalopathy in the United States.
    Neurology. 1992 Aug;42(8):1472-6 PMID: 1641138
  20. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex.
    J Immunol. 1992 Nov 1;149(9):3113-9 PMID: 1383338
  21. Correlates of SIV encephalitis in rhesus monkeys.
    J Med Primatol. 1992 Feb-May;21(2-3):59-63 PMID: 1359149
  22. Protection of monkeys by a split vaccine against SIVmac depends upon biological properties of the challenge virus.
    AIDS. 1993 Jun;7(6):787-95 PMID: 8363756
  23. Dynamics of the immune system response in cerebrospinal fluid and blood of SIVmac-infected rhesus monkeys.
    J Med Primatol. 1993 Feb-May;22(2-3):138-46 PMID: 8411105
  24. Different patterns of neuropathological disease in rhesus monkeys infected by simian immunodeficiency virus, and their relation to the humoral immune response.
    Neuropathol Appl Neurobiol. 1993 Aug;19(4):336-45 PMID: 8232754
  25. Neurobiology of simian and feline immunodeficiency virus infections.
    Brain Pathol. 1991 Apr;1(3):201-12 PMID: 1669709
  26. Neonatal disease induced by SIV infection of the rhesus monkey (Macaca mulatta).
    AIDS Res Hum Retroviruses. 1993 Nov;9(11):1131-7 PMID: 7508724
  27. Intrathecal synthesis of IgG in simian immunodeficiency virus (SIV)-infected rhesus macaques (Macaca mulatta).
    AIDS Res Hum Retroviruses. 1994 Jan;10(1):81-9 PMID: 8179966
  28. Cerebrospinal fluid p24 antigen levels and intrathecal immunoglobulin G synthesis are associated with cognitive disease severity in HIV-1.
    AIDS. 1994 Feb;8(2):197-204 PMID: 7913815
  29. T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS.
    Immunol Today. 1994 Jun;15(6):262-8 PMID: 7915115
  30. Intrathecal synthesis of anti-myelin basic protein IgG in HIV-1+ patients.
    Acta Neurol Scand. 1994 Oct;90(4):285-92 PMID: 7530889
  31. Transfer of neuropathogenic simian immunodeficiency virus with naturally infected microglia.
    Am J Pathol. 1995 Apr;146(4):914-23 PMID: 7717458
  32. Simian immunodeficiency virus (SIV)-specific CTL in cerebrospinal fluid and brains of SIV-infected rhesus macaques.
    J Immunol. 1995 May 15;154(10):5582-9 PMID: 7730657
  33. Early intrathecal events in rhesus macaques (Macaca mulatta) infected with pathogenic or nonpathogenic molecular clones of simian immunodeficiency virus.
    Lab Invest. 1995 May;72(5):547-58 PMID: 7745949
  34. Cytotoxic T lymphocytes and HIV-1 related neurologic disorders.
    Curr Top Microbiol Immunol. 1995;202:79-88 PMID: 7587372
  35. Contact of human immunodeficiency virus type 1-infected and uninfected CD4+ T lymphocytes is highly cytolytic for both cells.
    J Virol. 1995 Nov;69(11):6925-31 PMID: 7474110
  36. The effect of simian immunodeficiency virus infection in vitro and in vivo on the cytokine production of isolated microglia and peripheral macrophages from rhesus monkey.
    Virology. 1996 Jun 15;220(2):320-9 PMID: 8661383
  37. Pathogenesis of HIV-1 associated neurodegeneration.
    Crit Rev Neurobiol. 1996;10(1):57-67 PMID: 8853954
  38. Microglia-passaged simian immunodeficiency virus induces neurophysiological abnormalities in monkeys.
    Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14158-63 PMID: 8943077
  39. Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival.
    J Virol. 1997 Jan;71(1):284-90 PMID: 8985348
  40. HIV neuropathogenesis.
    J Neurovirol. 1997 May;3 Suppl 1:S14-5 PMID: 9179783
  41. Rapid disease progression without seroconversion following primary human immunodeficiency virus type 1 infection--evidence for highly susceptible human hosts.
    J Infect Dis. 1997 Jun;175(6):1352-9 PMID: 9180174
  42. Quinolinic acid and lymphocyte subsets in the intrathecal compartment as biomarkers of SIV infection and simian AIDS.
    AIDS Res Hum Retroviruses. 1997 Jul 1;13(10):891-7 PMID: 9197383
  43. The development of animal model systems for HIV-1 encephalitis and its associated dementia.
    J Neurovirol. 1995 Sep;1(3-4):229-43 PMID: 9222361
  44. Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV.
    Am J Pathol. 1997 Sep;151(3):793-803 PMID: 9284828
  45. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques.
    J Virol. 1998 Jan;72(1):164-9 PMID: 9420212
  46. SIV infection of macaques--modeling the progression to AIDS dementia.
    J Neurovirol. 1998 Jun;4(3):249-59 PMID: 9639068
  47. Transforming activity and antigenicity of an Epstein-Barr-like virus from lymphoblastoid cell lines of baboons with lymphoid disease.
    Intervirology. 1977;8(4):240-9 PMID: 194867
  48. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex.
    N Engl J Med. 1985 Dec 12;313(24):1498-504 PMID: 2999592
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1998-12-00
Pages
9940-7
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC110507
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com